The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Perceptive has introduced a structured approach that integrates imaging and Randomization Trial Supply Management (RTSM) services to support ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

STMicroelectronics and Innoscience sign GaN technology development and manufacturing agreement Joint Development Agreement (JDA) on GaN ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

While President Trump insisted that Americans would not bear the cost, new estimates imply that the burden of tariffs could fall heavily on consumers. Tariff Gambit Bets Americans Will Swallow ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Primo Brands Corporation Announces Secondary Offering of 45,000,000 Shares of Class A Common Stock by an Affiliate of One Rock Capital Partners ...